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EDITORIAL POLICIES
SCOPE OF THE JOURNAL
The Journal of Vascular Surgery is dedicated to
the science and art of vascular surgery and aims to
improve the management of patients with vascular
diseases by publishing relevant papers that report
important medical advances, test new hypotheses,
and address current controversies. To achieve this
goal, the Journal will publish original clinical and
laboratory studies and reports and papers that
comment on the social, economic, ethical, legal,
and political factors that relate to these aims.
PEER REVIEW
Principles of peer review.
Objectives The purpose of peer review is to help
ensure that the published papers are of the highest
quality by (1) advising the Editors on the originality
of the work, its importance relative to what has
already been published in the current literature, its
relevance to the objectives of the Journal, its scientiﬁc
creditability, and its acceptability for publication,
given the space that is available; and (2) by suggest-
ing changes and providing advice and assistance to
the authors on important aspects that may improve
the manuscript.
Fairness. The success of peer review requires that
all reviewers exercise careful scientiﬁc judgment, be
impartial and equitable, and form a balanced view
of the content of each manuscript. There is no
formula that can guide the reviewers in this task,
apart from the requirement to be objective and fair.
Conﬁdentiality. All documents and information
provided for the purpose of peer review must be kept
entirely conﬁdential. To prevent unauthorized access,
manuscripts must be stored in a secure manner. The
manuscript must not be shared with other colleagues.
If a reviewer wishes to seek a colleague’s opinion on
the scientiﬁc merit of a manuscript, the Editors must
be consulted ﬁrst, and the colleague must adhere to
the same standards of conﬁdentiality.
The manuscript must not be photocopied or
shared electronically. When the review is completed,
any personal electronic ﬁles should be deleted, and
any printed documents must be destroyed.
Any inquiries received by individual reviewers
about a manuscript should be referred to the Editors.
Conﬂict of interest. The decisions of the Editors
must be fair and objective and they must be seen to
be impartial. Because the ﬁnal decision on publica-
tion rests with the Editors, their decisions must not
be inﬂuenced by the Society for Vascular Surgery,
the afﬁliated vascular societies, or representatives of
companies, advertisers, government, or others who
might have conﬂicts of interest.22A JOURNAL OF VASCULAR SURGERY/July 2014Reviewers must decline to review any manuscript
applications with which they may have a conﬂict of
interest and should avoid reviewing any manuscript
if circumstances exist that could be viewed as
affecting their impartiality. For example, a reviewer
should not review a manuscript submitted by a
close personal friend, individuals from his or her insti-
tution, individuals with whom the reviewer has
collaborated, or a scientist with whom the reviewer
has had long-standing scientiﬁc or personal differ-
ences. When the reviewer is uncertain as to whether
a conﬂict exists, he or she should inform the Editor
of the circumstances and the Editor will make the
ﬁnal decision.
The peer review process. Fewer than half of the
manuscripts received by the Journal can be pub-
lished. The Editors and reviewers, by providing
prompt and authoritative review, aim to optimize
the quality of the published papers.
All submitted manuscripts are reviewed initially by
the Editors or Associate Editors. A submission may
be rejected outright if at least two of the Editors
conclude that it does not have sufﬁcient merit to
warrant further review or deals with subject matter
outside the scope of the Journal. Case reports may
be rejected by the decision of only one Editor.
Other manuscripts will be sent to at least one
member of the Editorial Board and two or three
additional reviewers. The identities of these reviewers
are kept conﬁdential. Reviewers are asked to give the
Editors a conﬁdential opinion on the importance,
originality, and scientiﬁc merit of the manuscript;
rank its importance relative to what has already
been published in the medical literature; rank its
importance regarding inclusion on the cover; and
suggest changes that will improve the paper.
A formal statistical review may be obtained to
ensure that the study population was clearly deﬁned,
that the design of the study was suitable, that appro-
priate statistical methods were used, and that the
subsequent conclusions were supported by the data
and their analysis.
If two manuscripts are received on the same
subject, unless both can be accommodated in the
Journal, priority in the review process will be given
to the manuscript that was submitted ﬁrst as deter-
mined by the submission date in the Editorial
Manager system. The Editor will promptly contact
the authors of the second manuscript to inform
them of the problem and give them the option of
submitting their manuscript to another journal.
Administrative issues related to peer review.
Authors are expected to comply with the published
Information for Authors. The Journal’s requirements
for submission of a manuscript are in accordance
with the “Uniform Requirements for Manuscripts
Submitted to Biomedical Journals: Writing and Edit-
ing for Biomedical Publication” published in JAMA
1997;277:927-34andavailableat http://www.icmje.
org/index.html. The Journal is a member of the
Committee on Publication Ethics (COPE). The Jour-
nal follows COPE Guidelines regarding misconduct.
These guidelines can be found at http://publi
cationethics.org/. Failure to adhere to these guide-
lines may negatively inﬂuence the opinions of the
Editors and reviewers, and thus the manuscript may
be returned to the author for appropriate revisions in
organization before it is sent out for peer review.
The Editors will convey the ﬁnal decision on the
disposition of the manuscript to the designated Cor-
responding author along with the reasons for the
decision and the complete or summarized comments
from the reviewers.
If revisions are requested, the Editors expect the
authors to revise the manuscript appropriately and
promptly to meet publication deadlines. The authors
must clearly indicate the changes that have been
made and/or explain their difference of opinion
with the reviewers. More speciﬁc directions can be
found in the Journal’s Information for Authors.
The Editors will send the reviewers a notiﬁcation
of their ﬁnal decision on the disposition of a manu-
script and, when appropriate to the review process,
the comments of other reviewers.
TRANSFER OF COPYRIGHT OWNERSHIP
TO THE JOURNAL
Before a manuscript can be published, the authors
must provide a signed agreement transferring, assign-
ing, or conveying all copyright ownership of their
manuscript to the Society for Vascular Surgery.
Hence, manuscripts accepted for publication become
the permanent property of the Society and may not
be published elsewhere by the authors without
written permission from the Publisher. Once the
manuscript has been accepted, the Publisher’s ofﬁce
will send a Copyright Transfer form to the corre-
sponding author. This form must be completed,
signed, and sent back to the Publisher’s ofﬁce without
delay. Copies of the copyright document will be kept
indeﬁnitely.
Manuscripts written by employees of the federal
government during the course of their ofﬁcial duties
may not be copyrightable. If the author falls under
this designation, it should be appropriately noted in
the Copyright Transfer form.
Subsequent to acceptance for publication, if the
authors withdraw their manuscript, the Journal may
make appropriate charges to cover the production
costs incurred.
An individual may make a single photocopy of
a published article for his or her personal use, but
multiple copies cannot be made without the written
permission of the Journal or from the Copyright
Clearance Center. Permissions can be sought by
contacting Elsevier directly at (215) 239-3804 or
by e-mail at healthpermissions@elsevier.com.ORIGINALITY OF MANUSCRIPT
The authors must certify that their article is orig-
inal, has been written by the stated authors, has not
been published previously, and is not under consider-
ation for publication by another journal. These, and
other warranties, are attested to when the Copyright
Transfer form is signed.
Previous presentations and abstracts. If the
work has been presented previously at a meeting as
an oral presentation or poster or has been published
in an abstract, a detailed report will be considered for
publication. However, the authors are expected to
submit the details of the previous presentations and
provide the abstracts. In general, manuscripts will
not be considered if the work had been published
previously in full-length conference proceedings or
as a book chapter.
Major update of a previous study. If the sub-
mitted manuscript is a major update on the results
of a previously published study, the authors must
submit copies of the previous papers so that the
Editors can determine whether the new paper
provides signiﬁcant new information or statistical
power to warrant publication. In general, such
updates should increase the number of patients by
at least 50% or the reported mean follow-up by at
least 2 years.
Media releases. The Editors recognize that news
organizations have the right to disseminate informa-
tion that may have been obtained from a presentation
at a scientiﬁc meeting or through direct discussions
with the author. It is the author’s responsibility to
inform the Editors that the work has been reported
previously by a journalist and explain the circum-
stances. In doing so, the authors should supply the
Editors with the original media report.
If the results of the study may potentially have
a major impact on patient management, the authors
can request the Editor’s consideration of prompt
review and publication.
Once submitted to the Journal, discussion of the
contents of a manuscript with the media must be
delayed until the review process is complete and
the manuscript is posted at the Journal’s Web site
pending publication unless the Editors provide prior
approval. If the authors provide additional informa-
tion to the media during the peer-review process,
the article may be rejected or withdrawn from
publication.
In some instances, the Editors may ask the authors
to prepare a brief press release summarizing the
manuscript. However, as with all papers, further
discussion of the results with the media must be
deferred until the acceptance and postings of the
manuscript.
Multiple publication. A joint publication or
secondary publication of a full-length paper in
another journal may be considered if the manuscript
contains important information that deserves to be
disseminated to a signiﬁcantly different readership
than that of the Journal. The Journal Editors mayJOURNAL OF VASCULAR SURGERY/July 2014 23A
grant permission for secondary publication in
another journal if the original report in the Journal
is appropriately acknowledged and the secondary
publication follows the initial publication in the Jour-
nal. Abstracts or full-length summaries of papers pre-
sented at meetings may be published simultaneously
in another journal with permission of the Editors of
both journals providing an appropriate acknowledg-
ment is made in each journal.
AUTHORSHIP
It is not appropriate to include an individual as an
author unless he or she has made a signiﬁcant contri-
bution to the conception or completion of the manu-
script and is willing to share the responsibility for the
content of the paper. Speciﬁcally, each of the authors
should have made a direct and substantial contribu-
tion to the following areas: (1) conceiving and
designing the study and/or analyzing and interpret-
ing the data; (2) writing the manuscript or providing
critical revisions that are important for the intellectual
content; and (3) approving the ﬁnal version of the
manuscript. For more information on the require-
ments for authorship, see the “Uniform Require-
ments for Manuscripts Submitted to Biomedical
Journals: Writing and Editing for Biomedical Publi-
cation” (http://www.icmje.org/index.html), sec-
tion II.A on Authorship and Contributorship.
Each of the authors will be expected to read the
Author Role, Originality and Conﬂict of Interest
form submitted by the corresponding author. By
signing the Copyright Transfer form once the paper
is accepted, the corresponding author attests to the
accuracy of the Author Role, Originality, and
Conﬂict of Interest form.
Generally, the maximum number of expected
authors for a clinical or basic research manuscript is
eight, and six for a case report or technical note.
The Editors request that additional authors be care-
fully examined with respect to the authorship criteria
listed above and suggest that some might better be
acknowledged than listed as authors. Further, the
Editors request that authors beyond this expected
number be speciﬁcally justiﬁed in the details section
of the electronic submission. In special circumstances
(eg, multicenter trials), the Editors will consider
additional authors on a case-by-case basis depending
on the speciﬁc circumstances for clinical or basic
research papers. As an alternative, a smaller number
of key authors may submit the work on behalf of
a larger research group, which can then be listed
and acknowledged in an appendix. If an author has
collaborated in a project but does not meet all the
requirements for authorship, he or she should be
recognized in the acknowledgment section of the
manuscript.
The Journal publishes an Author Contribution
Statement at the end of each clinical and basic
research manuscript. The information for this state-
ment should ﬁrst be submitted as part of the Author
Role form upon submission, and attested to by24A JOURNAL OF VASCULAR SURGERY/July 2014a completed Author Contribution Statement form
at the time of acceptance. For further information,
please see “Criteria for Authorship” J Vasc Surg
2005;42:599.
The order of the authors’ names is at the discre-
tion of the coauthors, who may wish to add a foot-
note explaining the order of authorship and/or
their contributions.
ORIGINAL DATA
The authors must be prepared to provide their
original data for review by the Editors and/or
reviewers if requested. The Author Role, Sponsor
Involvement, and Conﬂict of Interest form requires
the authors to produce the data on which the manu-
script is based for examination by the Editors or their
assignees, should they request it.
The authors are responsible for keeping their orig-
inal data and experimental notes on ﬁle for a reason-
able period of time in case a question should arise
about the manuscript after it has been published.
The authors should consider including a footnote
in the manuscript indicating their willingness to make
the original data available to other investigators
through electronic media to permit alternative anal-
ysis and/or inclusion in meta-analysis.
CLINICAL TRIAL REGISTRATION
In 2004, the International Committee of Medical
Journal Editors (ICMJE) recommended that clinical
trials be registered in a public database as a prerequi-
site for subsequent publication (De Angelis C, Dra-
zen JM, Frizelle FA, et al. Clinical trial registration:
a statement from the International Committee of
Medical Journal Editors. N Engl J Med 2004;351:
1250-1). The Journal of Vascular Surgery adopts
the policies recommended by the ICMJE and
requires the pre-registration of all prospective clinical
trials that have a control group (Cronenwett J,
Seeger J. Requirement for Registration of Clinical
Trials. J Vasc Surg 2007;45:1). In addition, the Jour-
nal requires the pre-registration of any commercially
sponsored clinical trial, including Phase I and II
trials. Clinical trials that meet the above requirement
and commence after July 1, 2007 must be registered
prior to enrollment of the ﬁrst patient. Relevant trials
that began before this date must be registered prior
to editorial review. Registration must be indicated
by providing the unique study number assigned at
www.clinicaltrials.gov, the principle site of registra-
tion sponsored by the National Library of Medi-
cine (NLM). Detailed directions and a tutorial for
registering a trial are available at http://prsinfo.
clinicaltrials.gov. Authors of unregistered trials or
those with inadequate information in the registry
will be given an opportunity to convince the Editors
that their rationale for omitting this was critical, but
it is the Journal’s expectation that clinical trials
involving prospective comparison of treatment or
any that are commercially sponsored will all be regis-
tered after July 1, 2007.
AUTHORS’ DISCLOSURE OF CONFLICTS
OF INTEREST
The authors’ university, institutional, and/or
corporate afﬁliations will be acknowledged on the
title page along with sources of funding. In addition,
the Journal expects the authors to disclose any
commercial associations that might represent a con-
ﬂict of interest in respect to the manuscript. If a com-
pany’s product is mentioned in a manuscript or other
articles, including letters to the Editor and Editorials,
all authors are expected to declare whether they have
a consulting or employment arrangement or a royalty
or stock agreement with the company. The authors
must indicate any conﬂicts of interest or the lack
thereof in the Author Role, Originality, and Conﬂict
of Interest form that is required before a manuscript
can be sent out for review.
A conﬂict of interest statement is published with
each paper (Johnston KW, Rutherford RB. Disclo-
sure of competition of interest. J Vasc Surg 1999;
30:200-2). If a paper is accepted for publication,
the authors will be asked to clarify and update their
competitive interest statements.
Failure to disclose a conﬂict of interest will be
dealt with according to the following, which has
been published in the Journal. (Johnston KW, Ruth-
erford RB. Failure to disclose competitive interest.
J Vasc Surg 2000;31:1306). “If it is brought to the
Editors’ attention that an author may have failed to
make an appropriate disclosure, the Editors will
give the author the opportunity to explain. If a satis-
factory explanation is not forthcoming, the Editors
will bring the issue to the attention of the author’s
institution for clariﬁcation. If the oversight can be
explained as an honest mistake, a simple notation
of the error will be published. If there was either
self-deception or a deliberate attempt to conceal
a signiﬁcant ﬁnancial competitive interest, the
Editors will conclude that this may represent an
attempt to deceive and may be a violation of public
and professional trust. The Editors may publish
a notation that the paper may be unreliable because
the author did not meet the standards of honest
disclosure of competitive interests required by the
Journal.”
ETHICAL AND ANIMAL
EXPERIMENTATION APPROVAL
Human subjects. Manuscripts that involve
research conducted on human subjects must follow
the principles outlined in the Declaration of Helsinki
(http://www.wma.net/e/policy/pdf/17c.pdf) and
include a statement in the Methods section that the
experimental protocol and informed consent were
approved by the Institutional Review Board and
that all subjects gave informed consent. The Editors
reserve the right to reject a manuscript if the authors
fail to make these statements in the manuscript or if,
at the request of the Editor, they do not provide
appropriate documentation that their studies had
appropriate approval by their Institutional ReviewBoard and that informed consent was obtained
from each patient.
Animal experiments. Manuscripts that report
animal experiments must include a statement in the
Methods section that the study was approved by
the Institutional Review Board and that the animal
care complied with the Guide for the Care and
Use of Laboratory Animals, Institute of Labo-
ratory Animal Resources, Commission on Life
Sciences, National Research Council. Washington:
National Academy Press, 1996. (http://stills.nap.
edu/readingroom/books/labrats/)
CONSENT TO REPRODUCE PREVIOUSLY
PUBLISHED DATA
It is the authors’ responsibility to obtain written
consent from the copyright owner to reproduce
direct quotations, tables, or illustrations that have
appeared in copyrighted material and to provide
complete information regarding their source. Simi-
larly, permission must be obtained for tables and
ﬁgures that have been modiﬁed from other
publications.
PATIENT CONSENT FOR REPRODUCING
PHOTOGRAPHS AND CASE HISTORIES
Photographs of identiﬁable persons must be
accompanied by signed releases from patients or
from both living parents or guardians of minors. As
per AMA Style, inserting black bars over the patient’s
eyes is insufﬁcient and may not be used. Similarly,
consent must be obtained if a person can be identi-
ﬁed from the case description.
COPYEDITING
A manuscript that is accepted for publication is
subject to copyediting so that it will conform to the
Journal’s standards and style. The revised manuscript
will be returned to the authors for approval. By
approving the changes, the authors accept the
responsibility for the changes made in their manu-
script by the copy editor.
SEQUENCE OF PUBLICATION
In general, manuscripts are published in the order
they are received, providing that the Journal receives
revisions in a timely fashion. Under unusual circum-
stances, a paper may be assigned priority for early
publication if, in the view of the Editors, it contains
important new information that should be brought
to the attention of the readers immediately.
PUBLISHED DISCUSSIONS
The discussions of papers presented at the Society
for Vascular Surgery’s Vascular Annual Meeting
and at some of the meetings of the afﬁliated societies
will be published with the manuscripts if they are
submitted in a timely fashion; however, these discus-
sions are subject to Editorial review and only those
that enhance the text or present alternative views
will be published.JOURNAL OF VASCULAR SURGERY/July 2014 25A
SCIENTIFIC MISCONDUCT
Misconduct in science was deﬁned by the National
Academy of Sciences, National Academy of Engi-
neering, and the Institute ofMedicine in 1992 as fabri-
cation (ie,making up) of data or results, falsiﬁcation (ie,
changing) of data or results, or plagiarism (ie, unautho-
rized use of the words, data, or ideas of another person
without giving appropriate credit) in proposing, per-
forming, or reporting research. Misconduct in science
does not include errors in the scientiﬁc method or in
experimental design or data interpretation. In dealing
with alleged scientiﬁc misconduct, the appropriate
steps in the process include informing the authors of
the allegations, requesting clariﬁcation, determining
whether the misconduct did or did not occur, and, to
the extent possible, establishing the intent, ascertaining
whether there were mitigating factors, and making
recommendations for appropriate action. If a charge
of scientiﬁc misconduct appears to be justiﬁed, it is
the Editors’ responsibility to refer the matter to the
appropriate individual at the authors’ university or
institution where the work was done. The university
or institution has the responsibility to investigate
alleged scientiﬁc misconduct.
If the charge of scientiﬁc misconduct is substanti-
ated, the Journal will print a retraction and may
impose sanctions that could include a restriction on
future publication in the Journal. The decision to
issue a retraction generally must be made by the
authors and/or the appropriate authorities at the
university or institution who have access to the full
details of the investigation. A published retraction
will include the title of the original article, the same
ﬁrst author as in the original paper, the reasons
why the article is being retracted, the circumstances
of the case, and a bibliographic reference to the orig-
inal paper. The retraction will be listed under a sepa-
rate heading in the Table of Contents.
CORRECTION OF ERRORS
As part of the scientiﬁc process, errors may be
discovered after publication that require clariﬁcation,
correction, or retraction of the paper. The Editor will26A JOURNAL OF VASCULAR SURGERY/July 2014handle errors on an individual basis after discussion
with the authors.
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